Celldex Therapeutics Inc (CLDX) — Capital Reinvestment Ratio
Celldex Therapeutics Inc (CLDX) has a Capital Reinvestment Ratio of 0.02x as of December 2008, meaning it reinvests 0% of its operating cash flow ($1.29 Million) in capital expenditures ($26.75K). Check CLDX intangible-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Celldex Therapeutics Inc Capital Reinvestment Ratio (2006–2008)
This chart tracks Celldex Therapeutics Inc's Capital Reinvestment Ratio across 2 annual periods. For the full cash flow conversion analysis, see Celldex Therapeutics Inc (CLDX) cash flow conversion.
Annual Capital Reinvestment Ratio for Celldex Therapeutics Inc (2006–2008)
Year-by-year Capital Reinvestment Ratio for Celldex Therapeutics Inc from 2006 to 2008. See Celldex Therapeutics Inc (CLDX) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2008 | 0.07x | $18.28 Million | $1.30 Million | ▼ -79.3% |
| 2006 | 0.35x | $27.00 Million | $9.32 Million | — |